Literature DB >> 19037518

In vitro activities of antifungal drugs against yeasts isolated from blood cultures and moulds isolated from various clinically significant sites in Singapore.

Ai Ling Tan1, Kian Sing Chan.   

Abstract

INTRODUCTION: Fungaemia carries with it high mortality rates and appropriate as well as timely antifungal therapy has been shown to be life saving.
MATERIALS AND METHODS: We studied the invitro activities of antifungal agents using the Etest method, against 100 Candida isolates from blood cultures, 10 Cryptococcus isolates from blood or cerebrospinal fluid and 50 mould isolates from various clinically significant sites of patients in Singapore General Hospital, from June 2004 to December 2006.
RESULTS: Overall, the yeasts appeared to have low minimum inhibitory concentrations (MICs) for all the 5 antifungal drugs tested except for fluconazole. The overall high MIC90 values of the moulds against the azoles were largely attributed to the non-Aspergillus moulds. Posaconazole, itraconazole, voriconazole and caspofungin appear effective against local strains of Aspergillus species, although there are no interpretive breakpoints.
CONCLUSIONS: The results show that the local fungal strains studied appear to be susceptible to the usual antifungal drugs recommended in the literature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19037518

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  2 in total

Review 1.  Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.

Authors:  Emily Zoller; Connie Valente; Kyle Baker; Michael E Klepser
Journal:  Drug Des Devel Ther       Date:  2010-11-04       Impact factor: 4.162

2.  DEP-Dots for 3D cell culture: low-cost, high-repeatability, effective 3D cell culture in multiple gel systems.

Authors:  Erin A Henslee; Carina M Dunlop; Christine M de Mel; Emily A Carter; Rula G Abdallat; Patrizia Camelliti; Fatima H Labeed
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.